Abstract
Bioactive peptides have emerged as promising therapeutic alternatives in pharmaceutical industry, especially to fight cancer. Here we aim to investigate the in vitro anti-proliferative activities and cell death mechanism of two series of hybrid peptides designed based on IsCT peptide (from Opithacantus madagascariensis) and A4 peptide (from Escherichia coli bacterial membrane anchor and aurein 1.2) against hepatocellular carcinoma cells. The ND series of hybrid peptides (IC50 ranging from 22 to 72 µg/ml) generally displayed higher cytotoxicity on all cell lines tested as compared to the DN peptides (IC50 ≥ 105 µg/ml). Among these peptides, DN1 and DN4 exhibited observable selectivity against HepG2 cells in a dose-dependent manner in the absence of cytostatic activity. DN1 and DN4 were shown to effectively kill HepG2 cells via minimum up-regulation of p53 accompanied with concurrent activation of both intrinsic and extrinsic apoptosis pathways that were cross-linked by Bid protein. We show that DN1 and DN4 induce selective cytotoxicity against HepG2 cells by triggering activation of intrinsic and extrinsic apoptosis pathways. Such concomitant activation of both apoptosis pathways to achieve efficient cytotoxicity may also reduce the likelihood of drug resistance development. In addition, cytotoxicity and selectivity of the hybrid peptides against HepG2 cells appeared to correlate with peptides’ cationicity and hydrophobicity. DN1 and DN4 showed potential to be further explored as an alternative in hepatocellular carcinoma and other primary cancer treatment. Further modulation of physicochemical properties of DN1 and DN4 can be done in search of novel ACP variants with enhanced potency as anticancer therapeutics.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed in the current study are available from the corresponding author on reasonable request.
References
Abbas R, Larisch S (2020) Targeting XIAP for promoting cancer cell death—the story of ARTS and SMAC. Cells 9(3):663
Aliabad HB, Falahati-Pour SK, Ahmadirad H, Mohamadi M, Hajizadeh MR, Bakhshi G, Mahmoodi M (2019) Vanadium complex induced apoptosis in HepG2 cells by the up-regulation of p53, p21, and caspase-8. WCRJ 6:e1293
Arpornsuwan T, Sriwai W, Jaresitthikunchai J, Phaonakrop N, Sritanaudomchai H, Roytrakul S (2014) Anticancer activities of antimicrobial BmKn2 peptides against oral and colon cancer cells. Int J Pept Res Ther 20(4):501–509
Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A (2018) How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ 25(1):104–113
Aziz MYA, Abu N, Yeap SK, Ho WY, Omar AR, Ismail NH et al (2016) Combinatorial cytotoxic effects of damnacanthal and doxorubicin against human breast cancer MCF-7 cells in vitro. Molecules 21(9):1228
Balogh J, Victor D III, Asham EH, Burroughs SG, Boktour M, Saharia A, Monsour HP Jr (2016) Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 3:41
Balusamy SR, Perumalsamy H, Huq MA, Balasubramanian B (2018) Anti-proliferative activity of Origanum vulgare inhibited lipogenesis and induced mitochondrial mediated apoptosis in human stomach cancer cell lines. Biomed Pharmacother 108:1835–1844
Borhani N, Manoochehri M, Gargari SS, Novin MG, Mansouri A, Omrani MD (2014) Decreased expression of proapoptotic genes caspase-8-and BCL2-associated agonist of cell death (BAD) in ovarian cancer. Clin Ovarian Other Gynecol Cancer 7(1–2):18–23
Bouattour M, Mehta N, He AR, Cohen EI, Nault J-C (2019) Systemic treatment for advanced hepatocellular carcinoma. Liver Cancer 8(5):341–358
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Bruix J, Qin S, Merle P, Granito A, Huang Y-H, Bodoky G et al (2017) Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 389(10064):56–66
Chang YS, Adnane J, Trail PA, Levy J, Henderson A, Xue D et al (2007) Sorafenib (BAY 43–9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. Cancer Chemother Pharmacol 59(5):561–574
Chen C, Yang C, Chen Y, Wang F, Mu Q, Zhang J et al (2016) Surface physical activity and hydrophobicity of designed helical peptide amphiphiles control their bioactivity and cell selectivity. ACS Appl Mater Interfaces 8(40):26501–26510
Chen Z, Han L, Xu M, Xu Y, Qian X (2013) Rationally designed multitarget anticancer agents. Curr Med Chem 20(13):1694–1714
Chiangjong W, Chutipongtanate S, Hongeng S (2020) Anticancer peptide: physicochemical property, functional aspect and trend in clinical application. Int J Oncol 57(3):678–696
Chin Y-T, Wang L-M, Hsieh M-T, Shih Y-J, Nana AW, Changou CA et al (2017) Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells. J Biomed Sci 24(1):1–13
Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81(1):136–147
Cutrona KJ, Kaufman BA, Figueroa DM, Elmore DE (2015) Role of arginine and lysine in the antimicrobial mechanism of histone-derived antimicrobial peptides. FEBS Lett 589(24):3915–3920
Dai L, Yasuda A, Naoki H, Corzo G, Andriantsiferana M, Nakajima T (2001) IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. Biochem Biophys Res Commun 286(4):820–825
De la Salud Bea R, Petraglia AF, Ascuitto MR, Buck QM (2017) Antibacterial activity and toxicity of analogs of scorpion venom IsCT peptides. Antibiotics 6(3):13
Deslouches B, Di YP (2017) Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget 8(28):46635
Edlich F (2018) BCL-2 proteins and apoptosis: recent insights and unknowns. Biochem Biophys Res Commun 500(1):26–34
Elkholi R, Floros KV, Chipuk JE (2011) The role of BH3-only proteins in tumor cell development, signaling, and treatment. Genes Cancer 2(5):523–537
Fan R, Yuan Y, Zhang Q, Zhou X-R, Jia L, Liu Z et al (2017) Isoleucine/leucine residues at “a” and “d” positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide. Amino Acids 49(1):193–202
Ferhi S, Santaniello S, Zerizer S, Cruciani S, Fadda A, Sanna D et al (2019) Total phenols from grape leaves counteract cell proliferation and modulate apoptosis-related gene expression in MCF-7 and HepG2 human cancer cell lines. Molecules 24(3):612
Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20(1):122–128
Ganne-Carrié N, Nahon P (2019) Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol 70(2):284–293
Harris F, Dennison SR, Singh J, Phoenix DA (2013) On the selectivity and efficacy of defense peptides with respect to cancer cells. Med Res Rev 33(1):190–234
Hilchie A, Hoskin D, Coombs MP (2019) Anticancer activities of natural and synthetic peptides. Antimicrob Pept 1117:131–147
Huang Y-B, Wang X-F, Wang H-Y, Liu Y, Chen Y (2011) Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework. Mol Cancer Ther 10(3):416–426
Huang Y, Feng Q, Yan Q, Hao X, Chen Y (2015) Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs. Mini Rev Med Chem 15(1):73–81
Ikeda M, Morizane C, Ueno M, Okusaka T, Ishii H, Furuse J (2018) Chemotherapy for hepatocellular carcinoma: current status and future perspectives. Jpn J Clin Oncol 48(2):103–114
Boohaker RJ, Lee WM, Vishnubhotla P, Perez JM, Khaled AR (2012) The use of therapeutic peptides to target and to kill cancer cells. Curr Med Chem 19(22):3794–3804
Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26(4):239–257
Khazaei S, Esa NM, Ramachandran V, Hamid RA, Pandurangan AK, Etemad A, Ismail P (2017a) In vitro antiproliferative and apoptosis inducing effect of Allium atroviolaceum bulb extract on breast, cervical, and liver cancer cells. Front Pharmacol 8:5
Khazaei S, Hamid RA, Esa NM, Ramachandran V, Aalam GTF, Etemad A, Ismail P (2017b) Promotion of HepG2 cell apoptosis by flower of Allium atroviolaceum and the mechanism of action. BMC Complement Altern Med 17(1):1–13
Kim MY (2020) Sasa quelpaertensis Nakai extract induces p53-independent apoptosis via the elevation of nitric oxide production in human HCT116 colon cancer cells. Oncol Lett 19(4):3027–3034
Koff JL, Ramachandiran S, Bernal-Mizrachi L (2015) A time to kill: targeting apoptosis in cancer. Int J Mol Sci 16(2):2942–2955
Korcsmáros T, Szalay MS, Böde C, Kovács IA, Csermely P (2007) How to design multi-target drugs: target search options in cellular networks. Expert Opin Drug Discov 2(6):799–808
Kudo M, Finn RS, Qin S, Han K-H, Ikeda K, Piscaglia F et al (2018) Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 391(10126):1163–1173
Kuo H-M, Tseng C-C, Chen N-F, Tai M-H, Hung H-C, Feng C-W et al (2018) MSP-4, an antimicrobial peptide, induces apoptosis via activation of extrinsic Fas/FasL- and intrinsic mitochondria-mediated pathways in one osteosarcoma cell line. Mar Drugs 16(1):8
Lau JL, Dunn MK (2018) Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem 26(10):2700–2707
Le C-F, Yusof MYM, Hassan H, Sekaran SD (2015a) In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin. Sci Rep 5(1):1–8
Le C-F, Yusof MYM, Hassan MAA, Lee VS, Isa DM, Sekaran SD (2015b) In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin. Sci Rep 5(1):1–15
Lee K, Shin SY, Kim K, Lim SS, Hahm K-S, Kim Y (2004) Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. Biochem Biophys Res Commun 323(2):712–719
Liu G, Liu Z, Yan Y, Wang H (2017) Effect of fraxetin on proliferation and apoptosis in breast cancer cells. Oncol Lett 14(6):7374–7378
Liu X, Cao R, Wang S, Jia J, Fei H (2016) Amphipathicity determines different cytotoxic mechanisms of lysine- or arginine-rich cationic hydrophobic peptides in cancer cells. J Med Chem 59(11):5238–5247
Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A et al (2002) Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 13(3):978–988
Nagata S (2000) Apoptotic DNA fragmentation. Exp Cell Res 256(1):12–18
Ndinguri MW, Solipuram R, Gambrell RP, Aggarwal S, Hammer RP (2009) Peptide targeting of platinum anti-cancer drugs. Bioconjug Chem 20(10):1869–1878
Obeng E (2021) Apoptosis (programmed cell death) and its signals—a review. Braz J Biol 81(4):1133–1143
Pasquereau-Kotula E, Habault J, Kroemer G, Poyet J-L (2018) The anticancer peptide RT53 induces immunogenic cell death. PLoS ONE 13(8):e0201220
Peña-Blanco A, García-Sáez AJ (2018) Bax, Bak and beyond—mitochondrial performance in apoptosis. FEBS J 285(3):416–431
Pfeffer CM, Singh AT (2018) Apoptosis: a target for anticancer therapy. Int J Mol Sci 19(2):448
Pramanik A, Ekberg K, Zhong Z, Shafqat J, Henriksson M, Jansson O et al (2001) C-peptide binding to human cell membranes: importance of Glu27. Biochem Biophys Res Commun 284(1):94–98
Prateep A, Sumkhemthong S, Suksomtip M, Chanvorachote P, Chaotham C (2017) Peptides extracted from edible mushroom: Lentinus squarrosulus induces apoptosis in human lung cancer cells. Pharm Biol 55(1):1792–1799
Rogawski MA (2000) Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents—toward an understanding of their favorable tolerability. Amino Acids 19(1):133–149
Saint Jean KD, Henderson KD, Chrom CL, Abiuso LE, Renn LM, Caputo GA (2018) Effects of hydrophobic amino acid substitutions on antimicrobial peptide behavior. Probiotics Antimicrob Proteins 10(3):408–419
Tahir AA, Sani NFA, Murad NA, Makpol S, Ngah WZW, Yusof YAM (2015) Combined ginger extract and Gelam honey modulate Ras/ERK and PI3K/AKT pathway genes in colon cancer HT29 cells. Nutr J 14(1):1–10
Theansungnoen T, Maijaroen S, Jangpromma N, Yaraksa N, Daduang S, Temsiripong T et al (2016) Cationic antimicrobial peptides derived from Crocodylus siamensis leukocyte extract, revealing anticancer activity and apoptotic induction on human cervical cancer cells. Protein J 35(3):202–211
Tripathi JK, Kathuria M, Kumar A, Mitra K, Ghosh JK (2015) An unprecedented alteration in mode of action of IsCT resulting its translocation into bacterial cytoplasm and inhibition of macromolecular syntheses. Sci Rep 5(1):1–10
Wang C, Qi R, Li N, Wang Z, An H, Zhang Q et al (2009) Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. J Biol Chem 284(24):16183–16190
Wang G, Keifer PA, Peterkofsky A (2003) Solution structure of the N-terminal amphitropic domain of Escherichia coli glucose-specific enzyme IIA in membrane-mimetic micelles. Protein Sci 12(5):1087–1096
Wang G, Li Y, Li X (2005) Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor. J Biol Chem 280(7):5803–5811
Wang J, Seebacher N, Shi H, Kan Q, Duan Z (2017) Novel strategies to prevent the development of multidrug resistance (MDR) in cancer. Oncotarget 8(48):84559
Wang Q, Zhang L, Yuan X, Ou Y, Zhu X, Cheng Z et al (2016) The relationship between the Bcl-2/Bax proteins and the mitochondria-mediated apoptosis pathway in the differentiation of adipose-derived stromal cells into neurons. PLoS ONE 11(10):e0163327
Wang W, Hu B, Qin J-J, Cheng J-W, Li X, Rajaei M et al (2019) A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance. Genes Dis 6(4):419–430
Wei Y, Yuan F, Zhou W, Wu L, Chen L, Wang J, Zhang Y (2016) Borax-induced apoptosis in HepG2 cells involves p53, Bcl-2, and Bax. Genet Mol Res. https://doi.org/10.4238/gmr.15028300
Xing J-Y, Song G-P, Deng J-P, Jiang L-Z, Xiong P, Yang B-J, Liu S-S (2015) Antitumor effects and mechanism of novel emodin rhamnoside derivatives against human cancer cells in vitro. PLoS ONE 10(12):e0144781
Zhu L, Han MB, Gao Y, Wang H, Dai L, Wen Y, Na LX (2015) Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes. Mol Med Rep 12(1):1151–1156
Acknowledgements
We acknowledge the support provided by Taylor’s University Centralised Laboratories throughout the research studies.
Funding
This study was supported by Taylor’s University, Lakeside Campus, Emerging Research Grant (TRGS/ERFS/2/2018/SBS/013) and Fundamental Research Grant Scheme (FRGS/1/2018/STG05/UNIM/03/1), Ministry of Education, Malaysia.
Author information
Authors and Affiliations
Contributions
CXN carried out all experiments, participated in all the statistical analysis and drafted the manuscript. CFL and YST participated in the study conceptualization, reviewed, and revised the manuscript. SHL conceived and administered the project design, supervised, reviewed, and revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ng, C.X., Le, C.F., Tor, Y.S. et al. Hybrid Anticancer Peptides DN1 and DN4 Exert Selective Cytotoxicity Against Hepatocellular Carcinoma Cells by Inducing Both Intrinsic and Extrinsic Apoptotic Pathways. Int J Pept Res Ther 27, 2757–2775 (2021). https://doi.org/10.1007/s10989-021-10288-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-021-10288-8